179 related articles for article (PubMed ID: 33570623)
1. Somatic GATA2 mutations define a subgroup of myeloid malignancy patients at high risk for invasive fungal disease.
Vedula RS; Cheng MP; Ronayne CE; Farmakiotis D; Ho VT; Koo S; Marty FM; Lindsley RC; Bold TD
Blood Adv; 2021 Jan; 5(1):54-60. PubMed ID: 33570623
[TBL] [Abstract][Full Text] [Related]
2. Invasive mucorales sinusitis in a young patient with Emberger syndrome and newly diagnosed AML: A case report and literature review of invasive fungal infections in GATA2 deficiency.
Chiu CY; Matsuo T; Wurster S; Gerstein Y; Hammond DE; Chien KS; DiNardo C; Kontoyiannis DP
Mycoses; 2023 Dec; 66(12):1029-1034. PubMed ID: 37550272
[TBL] [Abstract][Full Text] [Related]
3. GATA2 Deficiency: Predisposition to Myeloid Malignancy and Hematopoietic Cell Transplantation.
Rajput RV; Arnold DE
Curr Hematol Malig Rep; 2023 Aug; 18(4):89-97. PubMed ID: 37247092
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of invasive fungal disease in haematologic patients.
Souza L; Nouér SA; Morales H; Simões B; Solza C; Queiroz-Telles F; Nucci M
Mycoses; 2021 Mar; 64(3):252-256. PubMed ID: 33141969
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and risk factors for invasive fungal disease in liver transplant recipients in a tertiary transplant center.
Lum L; Lee A; Vu M; Strasser S; Davis R
Transpl Infect Dis; 2020 Dec; 22(6):e13361. PubMed ID: 32510755
[TBL] [Abstract][Full Text] [Related]
6. Myeloid malignancies with somatic
Alfayez M; Wang SA; Bannon SA; Kontoyiannis DP; Kornblau SM; Orange JS; Mace EM; DiNardo CD
Leuk Lymphoma; 2019 Aug; 60(8):2025-2033. PubMed ID: 30648453
[TBL] [Abstract][Full Text] [Related]
7. Invasive fungal disease in children with acute myeloid leukaemia: An Australian multicentre 10-year review.
Yeoh DK; Moore AS; Kotecha RS; Bartlett AW; Ryan AL; Cann MP; McMullan BJ; Thursky K; Slavin M; Blyth CC; Haeusler GM; Clark JE
Pediatr Blood Cancer; 2021 Nov; 68(11):e29275. PubMed ID: 34357688
[TBL] [Abstract][Full Text] [Related]
8. Empirical antifungal treatment for diagnosed and undiagnosed invasive fungal disease in patients with hematologic malignancies.
Deng Q; Lv HR; Lin XM; Zhao MF; Geng L; Li YM
Curr Med Res Opin; 2018 Jul; 34(7):1209-1216. PubMed ID: 28956459
[TBL] [Abstract][Full Text] [Related]
9. Pediatric Antifungal Prescribing Patterns Identify Significant Opportunities to Rationalize Antifungal Use in Children.
Ferreras-Antolín L; Irwin A; Atra A; Chapelle F; Drysdale SB; Emonts M; McMaster P; Paulus S; Patel S; Rompola M; Vergnano S; Whittaker E; Warris A
Pediatr Infect Dis J; 2022 Mar; 41(3):e69-e74. PubMed ID: 34784303
[TBL] [Abstract][Full Text] [Related]
10. [Breakthrough of invasive fungal disease with posaconazole as primary prophylaxis after induction chemotherapy for acute myeloid leukemia].
Pei RZ; Lu Y; Zhang PS; Liu XH; Chen D; Du XH; Sha KY; Li SY; Cao JJ; Chen LG; Zhuang XX; Tang SH
Zhonghua Nei Ke Za Zhi; 2020 Mar; 59(3):213-217. PubMed ID: 32146748
[No Abstract] [Full Text] [Related]
11. Evaluation of posaconazole antifungal prophylaxis in reducing the incidence of invasive aspergillosis in patients with acute myeloid leukemia.
Le Clech L; Uguen M; Quinio D; Nevez G; Couturier MA; Ianotto JC; Berthou C; Guillerm G; Le Bars H; Payan C; Narbonne V; Baron R; Saliou P
Curr Res Transl Med; 2020 Jan; 68(1):23-28. PubMed ID: 31787568
[TBL] [Abstract][Full Text] [Related]
12. Clinical risk score for invasive fungal diseases in patients with hematological malignancies undergoing chemotherapy: China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR) study.
Wang L; Wang Y; Hu J; Sun Y; Huang H; Chen J; Li J; Ma J; Li J; Liang Y; Wang J; Li Y; Yu K; Hu J; Jin J; Wang C; Wu D; Xiao Y; Huang X
Front Med; 2019 Jun; 13(3):365-377. PubMed ID: 30604166
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and treatment of fungal infections in allogeneic stem cell and solid organ transplant recipients.
Vehreschild JJ; Rüping MJ; Steinbach A; Cornely OA
Expert Opin Pharmacother; 2010 Jan; 11(1):95-113. PubMed ID: 20001432
[TBL] [Abstract][Full Text] [Related]
14. Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation.
West RR; Hsu AP; Holland SM; Cuellar-Rodriguez J; Hickstein DD
Haematologica; 2014 Feb; 99(2):276-81. PubMed ID: 24077845
[TBL] [Abstract][Full Text] [Related]
15. Somatic genetic alterations predict hematological progression in GATA2 deficiency.
Largeaud L; Collin M; Monselet N; Vergez F; Fregona V; Larcher L; Hirsch P; Duployez N; Bidet A; Luquet I; Bustamante J; Dufrechou S; Prade N; Nolla M; Hamelle C; Tavitian S; Habib C; Meynier M; Bellanne-Chantelot C; Donadieu J; De Fontbrune FS; Fieschi C; Ferster A; Delhommeau F; Delabesse E; Pasquet M
Haematologica; 2023 Jun; 108(6):1515-1529. PubMed ID: 36727400
[TBL] [Abstract][Full Text] [Related]
16. Invasive Fungal Disease Among Pediatric and Adolescent Patients Undergoing Itraconazole Prophylaxis After Hematopoietic Stem Cell Transplantation.
Itsaradisaikul S; Pakakasama S; Boonsathorn S; Techasaensiri C; Rattanasiri S; Apiwattanakul N
Transplant Proc; 2021; 53(6):2021-2028. PubMed ID: 33994183
[TBL] [Abstract][Full Text] [Related]
17. A targeted peritransplant antifungal strategy for the prevention of invasive fungal disease after lung transplantation: a sequential cohort analysis.
Koo S; Kubiak DW; Issa NC; Dietzek A; Boukedes S; Camp PC; Goldberg HJ; Baden LR; Fuhlbrigge AL; Marty FM
Transplantation; 2012 Aug; 94(3):281-6. PubMed ID: 22790447
[TBL] [Abstract][Full Text] [Related]
18. Antifungal prophylaxis with fluconazole in allogeneic stem cell transplantation recipients who had prior invasive aspergillosis with subsequent complete resolution by computed tomography.
Akahoshi Y; Kimura SI; Gomyo A; Hayakawa J; Tamaki M; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Kako S; Kanda Y
Infect Dis (Lond); 2018 Apr; 50(4):280-288. PubMed ID: 29087731
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and outcome of invasive fungal disease in children after hematopoietic cell transplantation or treated for malignancy: Impact of national programme of antifungal prophylaxis.
Czyżewski K; Gałązka P; Frączkiewicz J; Salamonowicz M; Szmydki-Baran A; Zając-Spychała O; Gryniewicz-Kwiatkowska O; Zalas-Więcek P; Chełmecka-Wiktorczyk L; Irga-Jaworska N; Bień E; Ociepa T; Wawryków P; Tomaszewska R; Płonowski M; Pierlejewski F; Gamrot-Pyka Z; Małas Z; Urbanek-Dądela A; Stolpa W; Zaucha-Prażmo A; Goździk J; Chaber R; Gil L; Styczyński J
Mycoses; 2019 Nov; 62(11):990-998. PubMed ID: 31429997
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the implementation rate of primary antifungal prophylaxis and the prognosis of invasive fungal disease in acute leukemia patients in China.
Xu XH; Zhang L; Cao XX; Li J; Zhang W; Zhu TN; Cai HC; Chen M; Han X; Yang C; Han B; Zhang Y; Zhuang JL; Zhou DB; Duan MH
J Infect Chemother; 2017 Jun; 23(6):360-367. PubMed ID: 28341518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
